NEPAFENAC TRADE DATA ANALYSIS
Analyze Nepafenac export import data and locate key markets, reliable suppliers, and active buyers by utilizing Eximpedia's data-centric platform.Whether you're a supplier looking for high-demand markets or a buyer sourcing apples from reliable exporters, Eximpedia’s data-driven approach for making informed trade decisions.
NEPAFENAC – Overview
Eximpedia analyses Nepafenac export import records, including data from 127 buyers and 66 suppliers. We provide an intelligence report of Apple that covers trade statistics, shipment values, quantities, exporters & importers, trade destinations, and HS codes.
Nepafenac Buyers, Suppliers & Shipments
Products Nepafenac import markets
Gain insights into Product Nepafenac with data on monthly import values, major importing countries, key ports, leading competitors, and active suppliers.
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 3004900000 | 6.17 | 41 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004900002 | 4.50 | 23 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049099 | 2.67 | 12 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30042019 | 2.57 | 16 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049059 | 1.39 | 3 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| BELGIUM | 10.95 | 59 | 0.00 |
| UNITED STATES | 4.60 | 34 | 0.00 |
| NULL | 1.61 | 14 | 0.00 |
| INDIA | 1.19 | 59 | 0.00 |
| 0.48 | 7 | 0.00 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| UA100200 | 6.17 | 41 | 0.00 |
| BOMBAY AIR CARGO | 5.60 | 30 | 0.00 |
| ISTANBUL AIRPORT CUSTOMS DIRECTORATE | 0.23 | 22 | 0.00 |
| 101 - CUSTOM HOUSE, DHAKA | 0.35 | 15 | 0.00 |
| LPAF | 0.20 | 12 | 0.00 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| JV OPTIMA FARM LIMITED | 2.21 | 1 |
| NOVARTIS VIETNAM COMPANY LIMITED | 1.39 | 518 |
| NOVARTIS PHARMA LLC | 2.21 | 270 |
| BADM LIMITED LIABILITY COMPANY | 3.60 | 1 |
| NOVARTIS HEALTHCARE PRIVATE LIMITED | 5.00 | 1401 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|
Discover the Hidden Opportunities in HS Code Nepafenac—access key decision-makers and detailed reports to save time and succeed.
Nepafenac Import Market
Explore Product Nepafenac with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 30042019 | NEVANAC 5ML - IND 741706 BATCH-1263L (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML)(IL/FF-000576 RC/FF-002191 DATE |  |
|
UNITED STATES | INDIA | 91272 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-11VTH (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML(X) IN) (IL/FF-000576 RC/FF-0021 | |
|
UNITED STATES | INDIA | 84672 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-11XEN (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) (IL/FF-000576 RC/FF-002 | |
|
UNITED STATES | INDIA | 91872 |
| 30042019 | (FOC) NEPAFENAC OPHTHALMIC SUSPENSION 0.1% W/V [IN HOUSE SPECIFICATION] (170 KIT)(REGULATORY SAMPLE) | |
|
SWITZERLAND | INDIA | 170 |
| 30042019 | (FOC) NEPAFENAC OPHTHALMIC SUSPENSION0.1% W/V [IN HOUSE SPECIFICATION] (170 KIT) (REGULATORY SAMPLE) | |
|
SWITZERLAND | INDIA | 170 |
| 30042019 | (FOC) NEPAFENAC OPHTHALMIC SUSPENSION 0.1% W/V [IN HOUSE SPECIFICATION] (170 KIT) (REGULATORY SAMPLE) | |
|
SWITZERLAND | INDIA | 170 |
| 30042019 | NEVANAC 5ML - IND 741706 BATCH-128JV (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) (IL/FF-000576 RC/FF-002 | |
|
UNITED STATES | INDIA | 79908 |
| 30042019 | NEVANAC 5ML - IND 741706 BATCH-11T5T (IL/FF-000576 RC/FF-002191 VALID DATE 14-SEP-2023) (NEPAFENAC OPHTHALMIC SUSPENSION | |
|
UNITED STATES | INDIA | 90348 |
| 30042019 | NEPAFENAC OPHTHALMIC SUSPENSION 0.3% W/V 3MG/ML LDPE 3ML (X)IN 753761 BATCH-VAF52A (ILEVRO) (IL/FF-000287 RC/FF-002118 | |
|
BELGIUM | INDIA | 21990 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-11XEM (NEPAFENAC OPHT.) (IL/FF-000576 RC/FF-002191 DATE 14 SEP 2023) | |
|
UNITED STATES | INDIA | 91560 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-12AF3 (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) | |
|
UNITED STATES | INDIA | 25116 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-12E9R (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) | |
|
UNITED STATES | INDIA | 90900 |
| 30042019 | NEVANAC 5ML - IND 741706 BATCH-12A8M (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) (IL/FF-000576 RC/FF-002 | |
|
UNITED STATES | INDIA | 63588 |
| 30042019 | NEPAFENAC OPHTHALMIC SUSPENSION 0.3% W/V 3MG/ML LDPE 3ML (X)IN 753761 BATCH-VCP21A (ILEVRO) (IL/FF-000287 RC/FF-002118 | |
|
BELGIUM | INDIA | 93820 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-11VTJ (NEPAFENAC OPHT.) (IL/FF-000576 RC/FF-002191 DATE 14 SEP 2023) | |
|
UNITED STATES | INDIA | 91296 |
| 30042019 | NEPAFENAC OPHTHALMIC SUSPENSION 0.3% W/V 3MG/ML LDPE 3ML (X)IN 753761 BATCH-VY604A (ILEVRO) (IL/FF-000287 RC/FF-002118 | |
|
BELGIUM | INDIA | 21908 |
| 30042019 | NEVANAC 5ML - IND 741706 BATCH-11UF0 (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) (IL/FF-000576 RC/FF-002 | |
|
UNITED STATES | INDIA | 92232 |
| 30042019 | NEPAFENAC OPHTHALMIC SUSPENSION 0.3% W/V 3MG/ML LDPE 3ML (X)IN 753761 BATCH-VY604A (ILEVRO) (IL/FF-000287 RC/FF-002118 | |
|
BELGIUM | INDIA | 21908 |
| 30042019 | NEPAFENAC OPHTHALMIC SUSPENSION 0.3% W/V 3MG/ML LDPE 3ML (X)IN 753761 BATCH-VCU87C (ILEVRO) (IL/FF-000287 RC/FF-002118 | |
|
BELGIUM | INDIA | 68320 |
| 30042019 | NEVANAC 5ML - IND 741706 BATCH-11UF1 (NEPAFENAC OPHTHALMIC SUSPENSION) (IL/FF-000576 RC/FF-002191 DATE 12-MAY-2022) | |
|
UNITED STATES | INDIA | 76776 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Products Nepafenac export markets
Discover Products Nepafenac with data on monthly export values, major exporting countries, key ports, leading competitors, and active buyers.
TOP EXPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 30049099 | 1.26 | 157 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 29420090 | 1.08 | 29 | 0.00 |
| OTHER ORGANIC COMPOUNDS | |||
| 29242990 | 0.79 | 38 | 0.00 |
| CARBOXYAMIDE-FUNCTION COMPOUNDS; AMIDE-FUNCTION COMPOUNDS OF CARBONIC ACID | |||
| 29143990 | 0.31 | 13 | 0.00 |
| KETONES AND QUINONES, WHETHER OR NOT WITH OTHER OXYGEN FUNCTION, AND THEIR HALOGENATED, SULPHONATED, NITRATED OR NITROSATED DERIVATIVES | |||
| 30049069 | 0.10 | 31 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
TOP EXPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| IRAQ | 0.78 | 4 | 0.00 |
| TURKEY | 0.70 | 22 | 0.00 |
| BANGLADESH | 0.43 | 10 | 0.00 |
| PAKISTAN | 0.34 | 25 | 0.00 |
| EGYPT | 0.30 | 13 | 0.00 |
TOP EXPORT PORTS
| PORTS | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| BOMBAY AIR CARGO | 2.19 | 306 | 0.00 |
| DELHI AIR CARGO | 0.10 | 60 | 0.00 |
| AHMEDABAD AIR CARGO | 0.06 | 32 | 0.00 |
| BANGALORE AIR CARGO | 0.30 | 24 | 0.00 |
| NHAVA SHEVA SEA | 0.85 | 19 | 0.00 |
TOP EXPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| FLAX LABORATORIES PRIVATE LIMITED | 0.24 | 150 |
| PRECISE BIO PHARMA PRIVATE LIMITED | 0.31 | 368 |
| ENALTEC LABS PRIVATE LIMITED | 1.02 | 681 |
| MICRO LABS LIMITED | 0.25 | 6478 |
| AJANTA PHARMA LIMITED | 1.06 | 4247 |
TOP EXPORT BUYERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| SHAMS AL THURAYA CO FOR | 0.10 | 11 |
| ABACUS PHARMA A LIMITED | 0.16 | 733 |
| AL THURAYA SCIENTIFIC DRUG BUREAU | 0.62 | 55 |
| HABIB BANK LIMITED | 0.17 | 335 |
| SHAHJALAL ISLAMI BANK LIMITED | 0.20 | 821 |
Access the complete database of 127 buyers and 66 suppliers with a one-time subscription plan.
Nepafenac Export Market
Analyze HSN Code Nepafenac with product description, export values, quantities, importer name, country of origin and key import destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS-NEVANAC OPTHALMICSUSPENSION (5 ML) NEPAFENAC | |
|
INDIA | CAYMAN ISLANDS | 10 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS-NEVANAC OPTHALMICSUSPENSION (5 ML) NEPAFENAC | |
|
INDIA | CAYMAN ISLANDS | 10 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS-NEVANAC OPTHALMICSUSPENSION (5 ML) NEPAFENAC | |
|
INDIA | CAYMAN ISLANDS | 30 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS:NEVANAC OPTHALMICSUSPENSION (5 ML) (NEPAFENAC) | |
|
INDIA | CAYMAN ISLANDS | 60 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - NEVANAC OPTHALMIC SUSPENSION (5 ML) (NEPAFENAC) | |
|
INDIA | ANTIGUA AND BARBUDA | 29 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - NEVANAC OPTHALMIC SUSPENSION (5 ML) (NEPAFENAC) | |
|
INDIA | ANTIGUA AND BARBUDA | 49 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - NEVANAC OPTHALMIC SUSPENSION (5 ML) (NEPAFENAC) | |
|
INDIA | ANTIGUA AND BARBUDA | 222 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS-NEVANAC OPTHALMIC SUSPENSION(5 ML) NEPAFENAC | |
|
INDIA | GRENADA | 16 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - NEVANAC OPTHALMIC SUSPENSION (5 ML) (NEPAFENAC) | |
|
INDIA | ANTIGUA AND BARBUDA | 111 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - NEVANAC OPTHALMIC SUSPENSION (5 ML) (NEPAFENAC) | |
|
INDIA | ANTIGUA AND BARBUDA | 69 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - NEVANAC OPTHALMIC SUSPENSION (5 ML) (NEPAFENAC) | |
|
INDIA | ANTIGUA AND BARBUDA | 28 |
| 30049099 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS-NEPAFLAM EYE DROP(5 ML) NEPAFENAC | |
|
INDIA | CAYMAN ISLANDS | 10 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS-NEVANAC OPTHALMICSUSPENSION (5 ML) NEPAFENAC | |
|
INDIA | CAYMAN ISLANDS | 80 |
| 30049099 | NEPAFLEM EYE DROP 5ML[17450X1=17450 PACKS][NEPAFENAC OPHTHALMIC SUSPENSION 0.1%W/V][NEPAFENAC -- 0.1%W/V AS PER INV | |
|
INDIA | IRAQ | 17450 |
| 30049099 | MICRONAC PF EYE DROPS 5ML. COMPOSITION:NEPAFENAC 0.1% W/V STABILIZED OXYCHLOROCOMPLEX 0.01% W/V (AS PRESERVATIVE) STER | |
|
INDIA | SEYCHELLES | 100 |
| 30049099 | MICRONAC PF EYE DROPS 5ML COMPOSITION: NEPAFENAC 0.1% W/V STABILIZED OXYCHLORO COMPLEX 0.01% W/V (AS PRESERVATIVE) STERI | |
|
INDIA | SEYCHELLES | 80 |
| 30049099 | NEVANAC OPHTALMIC SOLUTION 5ML COMPOSITION: EACH 5ML CONTAINS: NEPAFENAC 1MG PRESERVATIVE: BENZALKONIUM CHLORIDE NF 0.00 | |
|
INDIA | SEYCHELLES | 24 |
| 30049099 | NEVANAC OPHTALMIC SOLUTION 5ML (COMPOSITION: EACH ML CONTAINS: NEPAFENAC 1MG PRESERVATIVE: BENZALKONIUM CHLORIDE NF 0.00 | |
|
INDIA | SEYCHELLES | 120 |
| 30049099 | NEPLACT Z EYE DROPS 5ML-COMPOSITION: EACH ML CONTAINS: NEPAFENAC POLYHEXAMETHYLENE BIGUANIDE HYDROCHLORIDE 0.01 W/V (AS | |
|
INDIA | SEYCHELLES | 50 |
| 30049099 | MICRONAC PF EYE DROPS 5ML COMPOSITION: NEPAFENAC 0.1% W/V STABILIZED OXYCHLORO COMPLEX 0.01% W/V (AS PRESERVATIVE) STERI | |
|
INDIA | SEYCHELLES | 80 |
Why should you choose Eximpedia?
Deep-Analysis Report
Get reports on market trends, price, volume, HS Code supply, product details, country of origin, number of buyers & suppliers, and total shipments with Eximpedia's deep analysis reports.
Access Database Across 130+ Countries
Gain statistical and analytical reports, competitors' shipment records, and country-specific data from over 130 countries.
20 types of unique dashboards
Eximpedia offers 20 types of unique dashboards, tailored to meet diverse business needs. From trade insights to buyer analysis, each dashboard delivers actionable data at your fingertips.
Effortless Global Buyer Discovery
Explore international markets with ease! Access over 5 billion records to identify buyers in 130+ countries with just a click.
Supplier Stability Monitor
Leverage historical shipment data and real-time alerts for a complete view of supplier reliability and performance.
Competitor Pricing Strategy Intelligence
Utilise our data-driven platform to uncover competitors’ pricing strategies and track market pricing trends.